Cargando…
Targeting SUMOylation in Plasmodium as a Potential Target for Malaria Therapy
Malaria is a parasitic disease that represents a public health problem worldwide. Protozoans of the Plasmodium genus are responsible for causing malaria in humans. Plasmodium species have a complex life cycle that requires post-translational modifications (PTMs) to control cellular activities tempor...
Autores principales: | Sumam de Oliveira, Daffiny, Kronenberger, Thales, Palmisano, Giuseppe, Wrenger, Carsten, de Souza, Edmarcia Elisa |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8224225/ https://www.ncbi.nlm.nih.gov/pubmed/34178724 http://dx.doi.org/10.3389/fcimb.2021.685866 |
Ejemplares similares
-
Editorial: Emerging human viruses with pandemic potential: Diagnostics, pathogenesis, and therapeutics
por: Botosso, Viviane Fongaro, et al.
Publicado: (2023) -
Targeting plasmodium α-tubulin-1 to block malaria transmission to mosquitoes
por: Zhang, Genwei, et al.
Publicado: (2023) -
Structural Dynamics and Perspectives of Vitamin B6 Biosynthesis Enzymes in Plasmodium: Advances and Open Questions
por: Barra, Angélica Luana C., et al.
Publicado: (2021) -
Vitamin B6-Dependent Enzymes in the Human Malaria Parasite Plasmodium falciparum: A Druggable Target?
por: Kronenberger, Thales, et al.
Publicado: (2014) -
Melatonin Prevents Brain Damage and Neurocognitive Impairment Induced by Plasmodium Berghei ANKA Infection in Murine Model of Cerebral Malaria
por: Ataide, Brenda Jaqueline de Azevedo, et al.
Publicado: (2020)